Table 3 Comparison of laboratory tests in IBD patients with and without NAFLD.

From: The prevalence and predictors of non-alcoholic fatty liver disease in Chinese patients with inflammatory bowel disease: a multicenter retrospective study

Variables

NAFLD (n = 245)

non-NAFLD (n = 264)

P value

ALT, median (IQR), U/L

14.6 (10.0–21.0)

13.4 (9.5–20.9)

0.404

AST, median (IQR), U/L

18.0 (14.4–23.3)

17.9 (14.0–23.0)

0.709

GGT, median (IQR), U/L

22.0 (14.9–36.4)

18.1 (13.0-29.9)

0.004

ALP, median (IQR), U/L

75.4 (63.4–92.7)

77.0 (63.0-98.1)

0.595

Albumin, mean (SD), g/L

39.3 (6.2)

39.0 (6.3)

0.615

WBC, mean (SD), 109/L

6.5 (2.8)

6.7 (3.2)

0.440

Platelets, mean (SD), 109/L

243.5 (95.7)

250.9 (106.9)

0.410

ESR, mean (SD), mm/h

18.8 (19.7)

22.4 (21.1)

0.076

CRP, median (IQR), mg/L

5.0 (2.2–15.6)

5.3 (2.1–15.0)

0.890

Calprotectin, median (IQR), µg/g

34.2 (16.0-120.6)

46.5 (22.3-352.1)

0.248

Uric acid, median (IQR), µmol/L

293.0 (217.0-367.4)

271.0 (211.3–321.0)

0.013

Glycemia, median (IQR), mmol/L

4.8 (4.3–5.6)

4.6 (4.1-5.0)

< 0.001

Triglycerides, median (IQR), mmol/L

1.2 (0.9–1.7)

1.1 (0.7–1.4)

0.002

Cholesterol, mean (SD), mmol/L

4.2 (1.1)

4.1 (1.1)

0.394

LDL, mean (SD), mmol/L

2.5 (0.8)

2.3 (0.9)

0.019

HDL, median (IQR), mmol/L

1.1 (0.9–1.3)

1.1 (0.9–1.5)

0.117

Back to article page